Addition of Chidamide to the Combination Treatment of Decitabine Plus Camrelizumab in Combination Treatment Resistant/Relapsed Patients With Classical Hodgkin Lymphoma
PHASE2
This is a Phase II clinical trial for Decitabine plus Camrelizumab resistan...
Status
Unknown
Location
Biotherapeutic Department of Chinese PLA General Hospital
The Clinical Trial of Chidamide+Decitabine+Camrelizumab Versus Decitabine+Camrelizumab in Anti-PD-1 Antibody Resistant Patients With Classical Hodgkin Lymphoma.
PHASE2
This open-label, randomized, two-arm, phase 2 study has the primary objecti...
Status
Unknown
Location
Biotherapeutic Department of Chinese PLA General Hospital